RecruitingPhase 2NCT07002034
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Sponsor: Reunion Neuroscience Inc
Omaha, NE · +31 more sites
Parkinson's Disease clinical trials in Omaha, NE
6 recruiting parkinson's disease studies with a site in Omaha, NE.
RecruitingPhase 1 / Phase 2NCT04165070
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Sponsor: Merck Sharp & Dohme LLC
Omaha, NE · +17 more sites
RecruitingPhase not listedNCT04165798
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
Sponsor: Merck Sharp & Dohme LLC
Omaha, NE · +17 more sites
RecruitingNot applicableNCT04799470
Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease
Sponsor: University of Nebraska
Omaha, NE
RecruitingNot applicableNCT06899022
Attention and Eye Movement in Parkinson's Disease
Sponsor: University of Nebraska
Omaha, NE
RecruitingNot applicableNCT05070013
Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease (Aim 2)
Sponsor: University of Nebraska
Omaha, NE · +1 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.